News
14 Nov 2026
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
NDADrug ApprovalClinical Result
14 Nov 2026
Cell TherapyAcquisitionGene Therapy
14 Nov 2026
LEO Pharma announces NMPA-approval of Anzupgo® (delgocitinib) cream for patients with moderate to severe chronic hand eczema (CHE) in China
Clinical ResultDrug ApprovalLicense out/in
13 Nov 2026
Regeneron's NPR1-blocking antibody baloncibart scores Phase II win in POTS
Clinical Result
13 Nov 2026
Mammoth Biosciences Advances Lead Candidate MB-111 Toward the Clinic with the Presentation of Preclinical Durability and Safety Data at American Heart Association Scientific Sessions 2026
Clinical ResultAHA
Financing
13 Nov 2026
VaccineAcquisitionLicense out/in
13 Nov 2026
Phase 2
12 Nov 2026
Vittoria Biotherapeutics Announces FDA RMAT and Orphan Drug Designations for Senza5 CART5 (VIPER-101) in T-Cell Lymphoma
ImmunotherapyOrphan DrugCell TherapyASH